Cannell & Spears’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$56.5M Sell
550,416
-13,790
-2% -$1.56M 1.11% 24
2025
Q4
$70.7M Buy
564,206
+2,278
+0.4% +$290K 1.32% 20
2025
Q3
$75.3M Buy
561,928
+41,362
+8% +$5.43M 1.42% 17
2025
Q2
$70.8M Sell
520,566
-19,357
-4% -$2.55M 1.43% 15
2025
Q1
$71.6M Sell
539,923
-37,617
-7% -$4.79M 1.54% 10
2024
Q4
$65.3M Sell
577,540
-12,968
-2% -$1.5M 1.34% 16
2024
Q3
$67.3M Buy
590,508
+235,040
+66% +$25.8M 1.33% 16
2024
Q2
$36.9M Buy
355,468
+227
+0.1% +$24.1K 0.77% 41
2024
Q1
$40.4M Buy
355,241
+349,957
+6,623% +$40.1M 0.83% 40
2023
Q4
$582K Buy
5,284
+109
+2% +$10.9K 0.05% 133
2023
Q3
$501K Buy
5,175
+20
+0.4% +$2.1K 0.04% 134
2023
Q2
$562K Sell
5,155
-500
-9% -$53.3K 0.05% 131
2023
Q1
$573K Buy
5,655
+140
+3% +$14.8K 0.05% 124
2022
Q4
$605K Buy
5,515
+729
+15% +$75.5K 0.06% 114
2022
Q3
$463K Sell
4,786
-13
-0.3% -$1.39K 0.05% 124
2022
Q2
$521K Buy
4,799
+22
+0.5% +$2.5K 0.05% 126
2022
Q1
$565K Hold
4,777
0.04% 138
2021
Q4
$672K Buy
4,777
+1,265
+36% +$162K 0.05% 131
2021
Q3
$415K Hold
3,512
0.03% 157
2021
Q2
$407K Buy
3,512
+1,000
+40% +$117K 0.03% 165
2021
Q1
$301K Sell
2,512
-471
-16% -$55.8K 0.02% 184
2020
Q4
$327K Sell
2,983
-276
-8% -$30K 0.03% 174
2020
Q3
$355K Buy
+3,259
New +$331K 0.03% 156
2016
Q4
Sell
-13,782
Closed -$583K 133
2016
Q3
$583K Sell
13,782
-91
-0.7% -$3.9K 0.07% 74
2016
Q2
$545K Buy
+13,873
New +$552K 0.07% 71
2013
Q4
Sell
-10,992
Closed -$365K 124
2013
Q3
$365K Buy
+10,992
New +$386K 0.05% 83

Other funds holding ABT

Cannell & Spears's ABT Position: Q1 2026 in Review

Cannell & Spears reduced its Abbott (ABT) stake by 2.4% in Q1 2026, selling an estimated $1.56M and leaving 550,416 shares worth $56.5M. The position accounts for 1.11% of the portfolio, ranked #24.

Cannell & Spears first reported a position in ABT in Q3 2013 and has held it in 26 quarters since. The position peaked at $75.3M in Q3 2025. 3,083 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Cannell & Spears held 550,416 shares of Abbott worth $56.5M as of Q1 2026.
  • Cannell & Spears sold 13,790 Abbott shares in Q1 2026, an estimated $1.56M.
  • Abbott made up 1.11% of Cannell & Spears's portfolio in Q1 2026, its #24 holding.
  • Cannell & Spears first reported a position in Abbott in Q3 2013 and has held it in 26 quarters since.
  • Cannell & Spears's Abbott position peaked at $75.3M in Q3 2025.
  • 3,083 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Cannell & Spears's 13F filing for Q1 2026, filed 14 May 2026.